Differential prognostic values of mRNA expression of CEACAM gene family members in nonsmall cell lung cancer

References

• Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinoma by immunological tolerance and absorption techniques. J Exp Med. 1965;121:439–462.
   PubMed Web of Science ®Google Scholar
• Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 2013;32(3–4):643–671.
   PubMed Web of Science ®Google Scholar
• Chevinsky AH. CEA in tumors of other than colorectal origin. Semin Surg Oncol. 1991;7(3):162–166.
   Google Scholar
• Hasegawa T, Isobe K, Tsuchiya Y, Oikawa S, Nakazato H, Nakashima I, Shimokata K. Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer. Br J Cancer. 1993;67(1):58–65.
   Web of Science ®Google Scholar
• Allard WJ, Neaman IE, Elting JJ, Barnett TR, Yoshimura H, Fritsche HA, Yeung KK. Nonspecific cross-antigen 50/90 is elevated in patients with breast, lung, and colon cancer. Cancer Res. 1994;54(5):1227–1234.
   Web of Science ®Google Scholar
• Tchoupa AK, Schuhmacher T, Hauck CR. Signaling by epithelial members of the CEACAM family – mucosal docking sites for pathogenic bacteria. Cell Commun Signal. 2014;12:27.
   PubMed Web of Science ®Google Scholar
• Pavlopoulou A, Scorilas A. A comprehensive phylogenetic and structural analysis of the carcinoembryonic antigen (CEA) gene family. Genome Biol Evol. 2014;6(6):1314–1326.
   Web of Science ®Google Scholar
• Vincent RG, Chu TM, Fergen TB, Ostrander M. Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer. 1975;36(6):2069–2076.
   Web of Science ®Google Scholar
• Goslin RH, Skarin AT, Zamcheck N. Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancer. JAMA. 1981;246(19):2173–2176.
   Web of Science ®Google Scholar
• Lokich JJ. Plasma CEA levels in small cell lung cancer. Correlation with stage, distribution of metastases, and survival. Cancer. 1982;50(10):2154–2156.
   Web of Science ®Google Scholar
• Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Ann Thorac Surg. 2007;83(2):419–424.
   Web of Science ®Google Scholar
• Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32(3):435–439.
   Web of Science ®Google Scholar
• Matsuguma H, Nakahara R, Igarashi S, et al. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg. 2008;135(1):44–49.
   Web of Science ®Google Scholar
• Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T. Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level. Gen Thorac Cardiovasc Surg. 2009;57(6):303–306.
   Google Scholar
• Nakamura H, Saji H, Marushima H, Kimura H, Koizumi H, Takagi M. Associations between serum carcinoembryonic antigen levels and adenocarcinoma subtypes of the lung. Cancer Treat Commun. 2016;3:31–35.
   Google Scholar
• Berinstein NL. Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J Clin Oncol. 2002;20(8):2197–2207.
   PubMed Web of Science ®Google Scholar
• McCann KJ, Mander A, Cazaly A, et al. Targeting carcinoembryonic antigen with DNA vaccination: on-target adverse events link with immunological and clinical outcomes. Clin Cancer Res. 2016;22(19):4827–4836.
   Web of Science ®Google Scholar
• Aurisicchio L, Roscilli G, Marra E, Luberto L, Mancini R, La Monica N, Ciliberto G. Superior immunologic and therapeutic efficacy of a xenogeneic genetic cancer vaccine targeting carcinoembryonic human antigen. Hum Gene Ther. 2015;26(6):386–398.
   Web of Science ®Google Scholar
• Staff C, Magnusson CG, Hojjat-Farsangi M, et al. Induction of IgM, IgA and IgE antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein. J Clin Immunol. 2012;32(4):855–865.
   Web of Science ®Google Scholar
• Hong KP, Shin MH, Yoon S, et al. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity. Biomaterials. 2015;67:32–41.
   Web of Science ®Google Scholar
• Molina-Pinelo S, Gutierrez G, Pastor MD, et al. MicroRNA-dependent regulation of transcription in non-small cell lung cancer. PLoS One. 2014;9(3):e90524.
   Web of Science ®Google Scholar
• Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Ann. Surg. 2004;240(4):667–674; discussion 675–676.
   Web of Science ®Google Scholar
• Turriziani M, Fantini M, Benvenuto M, et al. Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trials. Recent Pat Anticancer Drug Discov. 2012;7(3):265–296.
   Web of Science ®Google Scholar
• Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013;8(12):e82241.
   PubMed Web of Science ®Google Scholar
• You Q, Guo H, Xu D. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer. Drug Des Devel Ther. 2015;9:5087–5097.
   PubMed Web of Science ®Google Scholar
• Raponi M, Zhang Y, Yu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res. 2006;66(15):7466–7472.
   PubMed Web of Science ®Google Scholar
• Zhu CQ, Ding K, Strumpf D, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol. 2010;28(29):4417–4424.
   PubMed Web of Science ®Google Scholar
• Hou J, Aerts J, den Hamer B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 2010;5(4):e10312.
   PubMed Web of Science ®Google Scholar
• Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439(7074):353–37.
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Yamaguchi R, Nakata A, et al. Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma. PLoS One. 2012;7(9):e43923.
   PubMed Web of Science ®Google Scholar
• Shedden K, Taylor JM, Enkemann SA, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med. 2008;14(8):822–827.
   PubMed Web of Science ®Google Scholar
• Hammerman PS, Hayes DN, Wilkerson MD, Schultz N, Bose R; Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519–525.
   PubMed Web of Science ®Google Scholar
• Xie Y, Xiao G, Coombes KR, et al. Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients. Clin Cancer Res. 2011;17(17):5705–5714.
   PubMed Web of Science ®Google Scholar
• Botling J, Edlund K, Lohr M, et al. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin Cancer Res. 2013;19(1):194–204.
   PubMed Web of Science ®Google Scholar
• Rousseaux S, Debernardi A, Jacquiau B, et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med. 2013;5(186):186ra66.
   PubMed Web of Science ®Google Scholar
• Girard L, Rodriguez-Canales J, Behrens C, et al. An expression signature as an aid to the histologic classification of non-small cell lung cancer. Clin Cancer Res. 2016;22(19):4880–4889.
   PubMed Web of Science ®Google Scholar
• Der SD, Sykes J, Pintilie M, et al. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. Thorac Oncol. 2014;9(1):59–64.
   PubMed Web of Science ®Google Scholar
• Li Q, Birkbak NJ, Gyorffy B, Szallasi Z, Eklund AC. Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics. 2011;12:474.
   PubMed Web of Science ®Google Scholar
• Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138–143.
   PubMed Web of Science ®Google Scholar
• Ford CH, Stokes HJ, Newman CE. Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels. Br J Cancer. 1981;44(2):145–153.
   Web of Science ®Google Scholar
• Wang XB, Li J, Han Y. Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis. Tumour Biol. 2014;35(10):10105–10110.
   Google Scholar
• Singer BB, Scheffrahn I, Kammerer R, Suttorp N, Ergun S, Slevogt H. Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells. PLoS One. 2010;5(1):e8747.
   PubMed Web of Science ®Google Scholar
• Thies A, Moll I, Berger J, et al. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol. 2002;20(10):2530–2536.
   Web of Science ®Google Scholar
• Zhou CJ, Liu B, Zhu KX, et al. The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas. Pathol Res Pract. 2009;205(7):483–489.
   Web of Science ®Google Scholar
• Liu W, Wei W, Winer D, et al. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene. 2007;26(19):2747–2758.
   Web of Science ®Google Scholar
• Laack E, Nikbakht H, Peters A, et al. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol. 2002;20(21):4279–4284.
   Web of Science ®Google Scholar
• Jantscheff P, Terracciano L, Lowy A, et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol. 2003;21(19):3638–3646.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Miki Y, Ebina M, et al. Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma. Br J Cancer. 2012;107(10):1745–1753.
   Web of Science ®Google Scholar
• Kim KS, Kim JT, Lee SJ, et al. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer. Clin Chim Acta. 2013;415:12–19.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Q, An Y, et al. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Int J Oncol. 2013;43(3):877–885.
   Web of Science ®Google Scholar
• Zang M, Zhang B, Zhang Y, et al. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. PLoS One. 2014;9(11):e112908.
   Web of Science ®Google Scholar